-
1
-
-
0038604480
-
Aspirin and hemostasis
-
Samama MM, Elalamy I. Aspirin and hemostasis. Rev Med Interne 2000;21(Suppl 1):27-34.
-
(2000)
Rev Med Interne
, vol.21
, Issue.SUPPL. 1
, pp. 27-34
-
-
Samama, M.M.1
Elalamy, I.2
-
2
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
3
-
-
0027447701
-
Aspirin response ana failure in cerebral infarction
-
Helgason CM, Tortorice KL, Winkler SR, et al. Aspirin response ana failure in cerebral infarction. Stroke 1993;24:345-50.
-
(1993)
Stroke
, vol.24
, pp. 345-350
-
-
Helgason, C.M.1
Tortorice, K.L.2
Winkler, S.R.3
-
4
-
-
0035421783
-
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
-
Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88:230-5.
-
(2001)
Am J Cardiol
, vol.88
, pp. 230-235
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Poggio, E.D.3
-
6
-
-
1542708471
-
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
-
Chen WH, Lee PY, Ng W, Tse HF, Lau CP. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 2004;43:1122-6.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1122-1126
-
-
Chen, W.H.1
Lee, P.Y.2
Ng, W.3
Tse, H.F.4
Lau, C.P.5
-
7
-
-
2342619016
-
Aspirin resistance in diabetic patients
-
de Gaetano G. Aspirin resistance in diabetic patients. Diabetes Care 2004;27:1244-5.
-
(2004)
Diabetes Care
, vol.27
, pp. 1244-1245
-
-
de Gaetano, G.1
-
8
-
-
1942501813
-
Actualités sur la résistance à l'aspirine en 2003
-
Christiaens L, Macchi L. Actualités sur la résistance à l'aspirine en 2003. Arch Mal Cœur 2004;97:320-6.
-
(2004)
Arch Mal Cœur
, vol.97
, pp. 320-326
-
-
Christiaens, L.1
Macchi, L.2
-
10
-
-
0037046196
-
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
-
Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105:1650-5.
-
(2002)
Circulation
, vol.105
, pp. 1650-1655
-
-
Eikelboom, J.W.1
Hirsh, J.2
Weitz, J.I.3
Johnston, M.4
Yi, Q.5
Yusuf, S.6
-
11
-
-
0037454168
-
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
-
Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:901-5.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 901-905
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Welsh, P.A.3
White, J.4
Topol, E.J.5
-
12
-
-
0025804692
-
Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease
-
Berglund U, Wallentin L. Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease. Eur Heart J 1991;12:428-33.
-
(1991)
Eur Heart J
, vol.12
, pp. 428-433
-
-
Berglund, U.1
Wallentin, L.2
-
13
-
-
0027970934
-
Development of aspirin resistance in persons with previous ischemic stroke
-
Helgason CM, Bolin KM, Hoff JA, et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke 1994;25:2331-6.
-
(1994)
Stroke
, vol.25
, pp. 2331-2336
-
-
Helgason, C.M.1
Bolin, K.M.2
Hoff, J.A.3
-
14
-
-
1542604069
-
Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients
-
Pulcinelli FM, Pignatelli P, Celestini A, Riondino S, Gazzaniga PP, Violi F. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol 2004;43:979-84.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 979-984
-
-
Pulcinelli, F.M.1
Pignatelli, P.2
Celestini, A.3
Riondino, S.4
Gazzaniga, P.P.5
Violi, F.6
-
15
-
-
0036826025
-
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease
-
Andersen K, Hurlen M, Arnesen H, Seljeflot I. Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res 2002;108:37-42.
-
(2002)
Thromb Res
, vol.108
, pp. 37-42
-
-
Andersen, K.1
Hurlen, M.2
Arnesen, H.3
Seljeflot, I.4
-
16
-
-
0346433909
-
In vitro aspirin resistance detected by PFA-100 closure time: Pivotal role of plasma von Willebrand factor
-
Chakroun T, Gerotziafas G, Robert F, et al. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004; 124:80-5.
-
(2004)
Br J Haematol
, vol.124
, pp. 80-85
-
-
Chakroun, T.1
Gerotziafas, G.2
Robert, F.3
-
17
-
-
0028934985
-
Individual variation in the effects of ASA on platelet function: Implications for the use of ASA clinically
-
Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 1995;11:221-7.
-
(1995)
Can J Cardiol
, vol.11
, pp. 221-227
-
-
Buchanan, M.R.1
Brister, S.J.2
-
18
-
-
3543005314
-
Platelet inhibition by aspirin is diminished in patients during carotid surgery: A form of transient aspirin resistance?
-
Payne DA, Jones CI, Hayes PD, Webster SE, Ross Naylor A, Goodall AH. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance? Thromb Haemost 2004;92:89-96.
-
(2004)
Thromb Haemost
, vol.92
, pp. 89-96
-
-
Payne, D.A.1
Jones, C.I.2
Hayes, P.D.3
Webster, S.E.4
Ross Naylor, A.5
Goodall, A.H.6
-
19
-
-
0141851094
-
Aspirin resistance: Definition, mechanisms and clinical read-outs
-
Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 2003;1:1710-3.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1710-1713
-
-
Patrono, C.1
-
20
-
-
0037442182
-
Effect of ibuprofen on cardioprotective effect of aspirin
-
MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003;361:573-4.
-
(2003)
Lancet
, vol.361
, pp. 573-574
-
-
MacDonald, T.M.1
Wei, L.2
-
21
-
-
0036878918
-
Resistance to aspirin in vitro at rest and during exercice in patients with angiographically proven coronary artery disease
-
Christiaens L, Macchi L, Herpin D, et al. Resistance to aspirin in vitro at rest and during exercice in patients with angiographically proven coronary artery disease. Thromb Res 2003;108:115-9.
-
(2003)
Thromb Res
, vol.108
, pp. 115-119
-
-
Christiaens, L.1
Macchi, L.2
Herpin, D.3
-
22
-
-
0042735242
-
Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms
-
Macchi L, Christiaens L, Brabant S, et al. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 2003;42:1115-9.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1115-1119
-
-
Macchi, L.1
Christiaens, L.2
Brabant, S.3
-
23
-
-
0037046174
-
Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?
-
Halushka MK, Halushka PV. Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2? Circulation 2002;105:1620-2.
-
(2002)
Circulation
, vol.105
, pp. 1620-1622
-
-
Halushka, M.K.1
Halushka, P.V.2
-
24
-
-
0038649988
-
Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
-
Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13.
-
(2003)
Circulation
, vol.107
, pp. 2908-2913
-
-
Gurbel, P.A.1
Bliden, K.P.2
Hiatt, B.L.3
O'Connor, C.M.4
-
25
-
-
0036379817
-
Individual variations of platelet inhibition after loading doses of clopidogrel
-
Jaremo P, Lindahl TL, Fransson SG, Richter A. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med 2002;252:233-8.
-
(2002)
J Intern Med
, vol.252
, pp. 233-238
-
-
Jaremo, P.1
Lindahl, T.L.2
Fransson, S.G.3
Richter, A.4
|